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) and the NCX inhibitor, SEA0400, were used to study the physiological role of NCX1 in mouse mesenteric arteries. NCX1 protein expression was greatly reduced in arteries from NCX1 SMϪ/Ϫ mice generated with Cre recombinase. Mean blood pressure (BP) was 6 -10 mmHg lower in NCX1 SMϪ/Ϫ mice than in wild-type (WT) controls. Vasoconstriction was studied in isolated, pressurized mesenteric small arteries from WT and NCX1 SMϪ/Ϫ mice and in heterozygotes with a global null mutation (NCX1 Fx/Ϫ ). Reduced NCX1 activity was manifested by a marked attenuation of responses to low extracellular Na ϩ concentration, nanomolar ouabain, and SEA0400. Myogenic tone (MT, 70 mmHg) was reduced by ϳ15% in NCX1 SMϪ/Ϫ arteries and, to a similar extent, by SEA0400 in WT arteries. MT was normal in arteries from NCX1 Fx/Ϫ mice, which had normal BP. Vasoconstrictions to phenylephrine and elevated extracellular K ϩ concentration were significantly reduced in NCX1 SMϪ/Ϫ arteries. Because a high extracellular K ϩ concentration-induced vasoconstriction involves the activation of L-type voltage-gated Ca 2ϩ channels (LVGCs), we measured LVGC-mediated currents and Ca 2ϩ sparklets in isolated mesenteric artery myocytes. Both the currents and the sparklets were significantly reduced in NCX1 SMϪ/Ϫ (vs. WT or NCX1 Fx/Ϫ ) myocytes, but the voltage-dependent inactivation of LVGCs was not augmented. An acute application of SEA0400 in WT myocytes had no effect on LVGC current. The LVGC agonist, Bay K 8644, eliminated the differences in LVGC currents and Ca 2ϩ sparklets between NCX1 SMϪ/Ϫ and control myocytes, suggesting that LVGC expression was normal in NCX1 SMϪ/Ϫ myocytes. Bay K 8644 did not, however, eliminate the difference in myogenic constriction between WT and NCX1 SMϪ/Ϫ arteries. We conclude that, under physiological conditions, NCX1-mediated Ca 2ϩ entry contributes significantly to the maintenance of MT. In NCX1 SMϪ/Ϫ mouse artery myocytes, the reduced Ca 2ϩ entry via NCX1 may lower cytosolic Ca 2ϩ concentration and thereby reduce MT and BP. The reduced LVGC activity may be the consequence of a low cytosolic Ca 2ϩ concentration. mesenteric arteries; myogenic tone; patch clamp; calcium sparklets; Bay K 8644 THE SODIUM/CALCIUM EXCHANGER (NCX), which can mediate both Ca 2ϩ exit and Ca 2ϩ entry in cells (5) , has been postulated to play a central role in arterial smooth muscle (SM) cell (ASMC) Ca 2ϩ handling and in the maintenance of arterial tone and blood pressure (BP) (4) . The block of NCX by the specific inhibitor, SEA0400 (25) , in small arteries preconstricted with a low-dose ouabain lowers the cytosolic Ca 2ϩ concentration ([Ca 2ϩ ] Cyt ) and induces vasodilation (21, 48) . Moreover, the SM-specific overexpression of NCX elevates BP and induces salt-dependent hypertension, and SEA0400 lowers BP in several salt-dependent animal models (21) . Indeed, NCX type-1 (NCX1) is upregulated in mesenteric arteries from rats with ouabain-induced hypertension (33) and pulmonary arteries from humans with primary pulmonary hypertension (49) . Whether NCX is involved in maintaining normal BP, however, has not been resolved. Here we employ a SM-specific knockout approach to examine the role of NCX in arterial contractility and the maintenance of vascular tone and BP.
Three isoforms of NCX have been identified: NCX1 is abundant in the heart and is ubiquitously expressed, whereas NCX2 and NCX3 are both restricted to brain and skeletal muscle (34) . NCX1 is the only isoform present in ASMCs, where two splice variants, NCX1.3 and NCX1.7, are expressed (27, 35) . In cardiac myocytes, NCX1 makes a major contribution to Ca 2ϩ extrusion during diastole (3, 11) . Nevertheless, cardiac-specific NCX1 knockout mice thrive: the loss of NCX1 is compensated by a reduced L-type voltage-gated Ca 2ϩ channel (LVGC) current and a shortened action potential because of accelerated Ca 2ϩ -dependent LVGC inactivation and augmented transient outward K ϩ current (18, 31, 32) . Importantly, cardiac NCX1-mediated Ca 2ϩ flux must be inward during depolarization and systole (5) . The situation is complicated, however, because exchanger-mediated fluxes depend on the relative activation of the exchanger, governed by cytosolic Na ϩ and Ca 2ϩ (26) , as well as on the net driving force, governed by the membrane potential (V m ) and the Na ϩ and Ca 2ϩ electrochemical gradients (5 should tend to operate close to its reversal potential (E Na/Ca ). This is determined by the Na ϩ and Ca 2ϩ electrochemical potentials, E Na and E Ca , respectively, and the 3 Na ϩ :1 Ca 2ϩ -coupling ratio: i.e., E Na/Ca ϭ 3E Na Ϫ 2E Ca (5 ] Cyt and myogenic tone (MT) suggested that NCX1 mediates (net) Ca 2ϩ entry in ASMCs within pressurized, tonically constricted small arteries (21, 36, 48 ). The present report shows that MT is also reduced, as is BP, in SM-specific knockout of NCX1 (NCX1 SMϪ/Ϫ ) mice. This is consistent with the view (21) that NCX1 normally mediates Ca 2ϩ entry in tonically constricted small arteries. Reduced ASMC NCX1 expression is, however, as in heart (32), accompanied by a functional reduction in Ca 2ϩ entry via LVGCs. The latter is normally a major contributor to MT (8, 20, 47) . But, in contrast to cardiac muscle where elevated [Ca 2ϩ ] Cyt in cardiac muscle-specific NCX1 knockout mice accelerates LVGC inactivation, the reduced MT and low BP suggest that [Ca 2ϩ ] Cyt may be low in NCX1 SMϪ/Ϫ mice. This could explain the reduced protein kinase C-dependent phosphorylation of LVGCs and, thus, reduced LVGC activation in ASMCs (37) .
METHODS

Experimental Animals
Ethical approval. All mouse protocols were approved by the Institutional Animal Care and Use Committee of the University of Maryland School of Medicine.
Generation of NCX SMϪ/Ϫ mice. NCX SMϪ/Ϫ mice were generated by crossing homozygous NCX1 LoxP [floxed (Fx)] mice (NCX1 Fx/Fx ) (18) with hemizygous SM-specific Cre recombinase mice (Cre SMϩ ) (46) . These genetically altered mice are on a C57BL/6J background [denoted as wild-type (WT)] and are congenic with their littermates. The NCX1 exon 11 in NCX1 Fx/Fx mice is flanked by two LoxP sites (Fig. 1A) (18) . Cre SMϩ mice were generated by inserting the Cre gene, under the control of the SM myosin heavy chain (MHC) promoter, randomly into the mouse genome. This construct also contained an internal ribosomal entry site and enhanced green fluorescent protein (eGFP) downstream from the Cre recombinase (Fig. 1A) to enable simultaneous transcription, but independent translation, of these genes. When the SM-MHC promoter is activated in SM cells, both Cre and eGFP are expressed; the GFP can be visualized by its fluorescence. In these myocytes, Cre excises the genomic exon 11 DNA between the LoxP sites, leaving one intact LoxP site and the gene for a truncated, nonfunctional NCX1.
When Cre is expressed in a tissue-specific manner in mice that are homozygous for a floxed gene, both copies of the gene should, theoretically, be excised from the genome only in the target cells to generate a tissue-specific knockout mouse. Although the SM-MHC promoter restricts the adult expression to SM (46) , it is also active transiently during male gametogenesis (9, 10, 16) , resulting in the recombination of NCX1 exon 11 in meiotic cells. Thus crosses of female NCX1
Fx/Fx mice with male NCX1 Fx/ϩ -Cre SMϩ mice (i.e., floxed heterozygotes with a SM-specific Cre gene) produced either NCX1 Fx/Ϫ (-Cre Ϫ ) or NCX1 Fx/Ϫ -Cre SMϩ (ϭNCX1 SMϪ/Ϫ ) mice. The latter contain one globally deleted allele and one SM-specific-deleted allele; i.e., they were SM-specific NCX1 knockout mice. Controls for NCX1 SMϪ/Ϫ mice were NCX1 Fx/Ϫ littermates as well as C57BL/6J WT mice. Genomic DNA, obtained from tail biopsies, was used for genotyping by PCR. Primers for the floxed exon 11 were designed to distinguish the WT, floxed, and deleted alleles (Fig. 1B) .
BP Measurements
Telemetric BP measurement. WT, NCX1
Fx/Ϫ , and NCX1 SMϪ/Ϫ mice (ϳ16 wk old) were anesthetized with isoflurane supplemented with 100% O 2. The right common carotid artery was exposed and ligated via an anterior neck midline incision. Telemetric BP sensors The SM-specific Cre recombinase gene (SM-Cre) contains an internal ribosome entry site (IRES) and green fluorescent protein (GFP) under the control of the SMmyosin heavy chain (SM-MHC) promoter (top). This gene is randomly inserted into the genome of mice in which exon 11 of the NCX1 genomic sequence is replaced with a floxed exon 11 (middle). When Cre is expressed, the sequence between the LoxP sites, exon 11, is removed leaving 1 innocuous LoxP site (bottom). When the gene is activated, a nonfunctional, truncated NCX1 protein is synthesized and degraded. B: amplification of the wild-type (WT, ϩ), floxed (Fx), and deleted (Del) alleles. PCR primers were designed to anneal to the genomic sequence flanking the LoxP sites indicated in A. These primers amplify all possible combinations of alleles as indicated by the genotypes at the tops of the lanes. C: myocytes are visualized by the GFP fluorescence in the myocytes of a cannulated, pressurized mesenteric small artery; some myocytes do not exhibit GFP fluorescence (white asterisk). D: NCX1 protein expression detected by immunoblot in aorta, heart, mesenteric artery, and urinary bladder from WT, NCX1
Fx/Ϫ , and NCX1 SMϪ/Ϫ mice; glutaraldehyde-3-dehydrogenase (GAPDH) or ␤-actin was used as a housekeeping protein, as indicated.
(DSI TA11PA-C10, Data Science International, Minneapolis, MN) were used. The catheter of the BP sensor was inserted into a small hole proximal to the ligature, the tip was passed to the origin of the carotid at the aortic arch, and the catheter was fixed in place with a suture and the hole sealed with adhesive (Vetbond, 3M, St. Paul, MN). The body of the sensor was passed through a subcutaneous tunnel to a subcutaneous pocket in the abdominal wall. Following 7-10 days of recovery from surgery, 24- Fx/Ϫ , and NCX1 SMϪ/Ϫ mice (12-16 wk of age) were euthanized with a CO2 overdose followed by cervical dislocation. Small arteries from the superior mesenteric artery arcade were isolated and cannulated at both ends. Arterial diameter, myogenic reactivity, MT, and evoked vasoconstriction were measured in the isolated, pressurized arteries as described (48 ]Cyt and diameter measurements, pressurized arteries from WT mice were loaded with fluo-4. Details of the dye-loading procedure and imaging methods are published (48) . Similar methods were used for GFP fluorescence measurements in NCX1 SMϪ/Ϫ arteries. Briefly, the pressurized arteries were imaged with a Nipkow-Yokogawa spinning disc confocal imaging system (CSU-10; Solamere Technology, Salt Lake City, UT) mounted on a Nikon Eclipse TE2000-U inverted microscope (ϫ60; numerical aperture, 1.2; water immersion objective). Fluorescence was excited at 488 nm (argon ion laser). Optical sections of the arterial wall (106 m ϫ 70 m, and containing 20 -35 cells) were imaged with a Stanford XR-Mega 10 camera (Stanford Photonics, Palo Alto, CA) at 1-30 frames/s using a video-capture board (PCI 1407, National Instruments, Austin, TX).
Immunoblot Analysis
Aorta, main mesenteric artery, urinary bladder, heart, and brain were dissected, minced, and homogenized in homogenization medium, and the membrane fractions were prepared to assay NCX protein expression. Tissue extracts were analyzed (48) with specific monoclonal NCX1 antibody (R3F1, from K. D. Philipson, University of California, Los Angeles, CA). Band intensities were quantified with ID image analysis software (Eastman Kodak, Rochester, NY) (17) and normalized with ␤-actin or glyceraldehyde-3-phosphate dehydrogenase to control for protein loading.
Arterial Myocyte Isolation
Male WT, NCX1
Fx/Ϫ , and NCX1 SMϪ/Ϫ mice (12-16 wk of age) were euthanized with CO2 followed by cervical dislocation. The main mesenteric artery was removed, cleaned, and used for myocyte isolation. The artery was digested for 35 min at 37°C in low-Ca 2ϩ PSS containing (in mg/ml) 1.5 collagenase type XI, 0.16 elastase type IV, and 1 bovine serum albumin, and individual myocytes were dissociated by trituration (2, 47) . Only cells with elongated morphology (i.e., relaxed cells) were studied.
Patch-Clamp Recording
Whole cell, patch-clamp configuration was applied to record membrane currents using an Axopatch 200 patch-clamp amplifier (Axon Instruments, Union City, CA), as described (47) . Fire-polished micropipettes (1-3 M⍀ resistance) were manufactured from borosilicate capillary tubing (Garner Glass, Claremont, CA) using a micropipette puller (model P-97, Sutter Instruments, Novato, CA). An Ag-AgCl reference electrode was connected to the bath using an agar salt bridge containing 1 M KCl. Before the pipette approached the cell, the chamber was perfused with Ca 2ϩ -free PSS containing 1.4 mM extracellular Mg 2ϩ concentration to prevent cell contraction caused by ATP diffusing from the pipette. After seal formation, the cells were superfused with normal PSS. The holding potential was Ϫ70 mV in all experiments. The leak and capacity transients were subtracted using a P/4 protocol. The series resistance was compensated to give the fastest possible capacity transient without producing oscillations. The membrane currents were recorded with 12-bit analog-to-digital converters (Digidata 1322A, Axon Instruments). Data were sampled at 500 kHz (unless otherwise stated), filtered at 5 kHz with a 902LPF low-pass Bessel filter (Frequency Devices, Haverhill, MA), and stored for subsequent analysis. All records were obtained at room temperature (25-26°C).
Macroscopic currents were recorded using 15-ms voltage clamp steps to a range of potentials from Ϫ50 to ϩ90 mV. Preliminary experiments showed that LVGC currents carried by Ca 2ϩ were small and difficult to measure accurately; therefore, we used Ba 2ϩ as the current carrier. To construct current-voltage curves, the current during the pulse (I Ba) is plotted as a function of pulse voltage. Because the amplitude of the tail current following the pulse (ϪItail) is a measure of the conductance activated during the pulse, conductance-voltage (G-V) curves are obtained by plotting ϪI tail as a function of pulse voltage.
Recording of Ca 2ϩ Sparklets
Detailed methods for recording Ca 2ϩ sparklets are published (28, 29) . Briefly, Ca 2ϩ sparklets were recorded using a total internal reflection fluorescence microscope (Olympus, South Windsor, CT). Cells were loaded with the Ca 2ϩ indicator Fluo-5F. Images were acquired at 30 -90 Hz. Background-subtracted fluorescence signals were converted to concentration units using the F max equation (28, 47) . Ca 2ϩ sparklets were detected and defined for analysis using an automated algorithm written in Interactive Data Language software (IDL, Research Systems, Boulder, CO). Ca 2ϩ sparklets had an amplitude equal to or larger than the mean basal [Ca 2ϩ ]Cyt plus three times its standard deviation. For a [Ca 2ϩ ]Cyt elevation to be considered a sparklet, a grid of 3 ϫ 3 contiguous pixels had to have a [Ca 2ϩ ]Cyt value at or above the amplitude threshold.
Reagents and Solutions
The artery dissection solution contained (in mM) 145 NaCl, 4.7 KCl, 1.2 MgSO 4·7H2O, 2 MOPS, 0.02 EDTA, 1.2 NaH2PO4, 2 CaCl2·2H2O, 5 glucose, and 2.0 pyruvate and 1% albumin (pH 7.4 at 5°C). The PSS perfusion solution contained (in mM) 112 NaCl, 25.7 NaHCO 3, 4.9 KCl, 2.5 CaCl2, 1.2 MgSO4·7H2O, 1.2 KH2PO4, 11.5 glucose, and 10 HEPES (adjusted pH to 7.3-7.4 with NaOH). High (10 - solution was made by replacing 112 mM NaCl with equimolar LiCl; 25.7 mM NaHCO 3 was retained to minimize the perturbation of the acid-base balance. Solutions were gassed with 5% O2-5% CO2-90% N2 (48) . The tissue homogenization medium contained (in mM) 140 NaCl, 10 NaH 2PO4, 2 EDTA, and 10 NaN3 and 2.5ϫ concentrated Roche (Hoffmann-La Roche, Nutley, NJ) complete protease inhibitor cocktail.
To isolate Ba 2ϩ currents (IBa) in electrophysiological experiments, the pipette was filled with high Cs ϩ solution of the following composition: (in mM) 130 CsCl, 2.5 MgCl2, 10 HEPES, 10 EGTA, and 2 Na2ATP (pH was adjusted to 7.2 with CsOH). The bath solution contained (in mM) 140 NaCl, 2.7 KCl, 10 BaCl2, and 10 HEPES (pH was adjusted to 7.4 with NaOH). All experiments were performed in the presence of 200 nM tetrodotoxin (TTX) to block the Na ϩ currents previously described in these cells (2) . The osmolarity of all internal and external solutions was maintained at 271 and 296 Ϯ 1 mosmol/l, respectively. Osmolarity was measured with a model 5500 vapor pressure osmometer (Wescor, Logan, UT).
Reagents and sources were as follows: ouabain, phenylepherine, nifedipine, collagenase, elastase, and bovine serum albumin (SigmaAldrich, St. Louis, MO); SEA0400 (Taisho Pharmaceutical, Tokyo, Japan); and TTX and Bay K 8644 (Calbiochem, San Diego, CA). Other reagents were reagent grade or the highest grade available. TTX was dissolved in deionized water; nifedipine was dissolved in DMSO.
Data Analysis and Statistics
The data are expressed as means Ϯ SE; n denotes the number of animals, the number of arteries studied (1 artery per animal), or the number of cells studied in electrophysiological experiments. Comparisons of data were made using Student's paired or unpaired t-test, as appropriate; one-way or two-way ANOVA was used where indicated. Differences were considered significant at P Ͻ 0.05. Electrophysiological data analysis was performed using pClamp software (version 9.0; Axon Instruments). I Ba amplitudes were measured relative to the current level before the pulse.
To characterize the voltage dependence of LVGC activation, we fit G-V curves with a Boltzman equation of the following form:
where ϪItail(Vm) is the magnitude of Itail following a step to Vm, ϪItail,max is the maximum tail current, V0.5 is the voltage at which the conductance (i.e., the ϪItail magnitude) is half-maximal, and k is the slope factor.
RESULTS
NCX1 Protein Expression Is Reduced in NCX1 SMϪ/Ϫ Mouse Arteries
The expression of Cre recombinase, and thus the excision of NCX1 exon 11 in arterial myocytes of NCX1 SMϪ/Ϫ mice, was verified by the simultaneous expression of eGFP. GFP fluorescence was observed in about 75-90% of the myocytes in the NCX1 SMϪ/Ϫ mouse mesenteric small arteries employed in physiological experiments (Fig. 1C) . There was, however, substantial variability not only from artery to artery but also from region to region in a single artery. The absence of a GFP signal in some myocytes (Fig. 1C ) may indicate that Cre was not expressed in these cells or that it was only transiently expressed, in which case, NCX1 exon 11 should already have been excised.
The downregulation of normal NCX1 expression in these arteries was confirmed by immunoblot. In cardiac muscle, NCX1 appears as two bands, at 160 and 120 kDa. The relative expression of these bands varies, however, depending on the redox conditions used for membrane preparation (14) ; the 120-kDa band predominates under our conditions (Fig. 1D) . In cardiac-specific knockout of NCX1, the intensities of both bands are reduced and a new, truncated NCX1 band appears at ϳ110 kDa (18) . As illustrated in Fig. 1D , comparable results are obtained in the arteries of WT and NCX1 SMϪ/Ϫ mice, although some bands appear slightly smaller (ϳ140, ϳ120, and ϳ90 kDa, respectively). Only the two larger bands are observed in arteries from WT mice. The intensity of the 120-kDa band, which predominates in WT arteries, is reduced by about half in NCX1
Fx/Ϫ mouse arteries and by ϳ80 -90% in NCX1 SMϪ/Ϫ arteries; a new, truncated, ϳ90-kDa band is then observed. The NCX1 expression is similarly reduced in urinary bladders from NCX1
Fx/Ϫ and NCX1 SMϪ/Ϫ mice (Fig. 1D ). Quantification is difficult, however, because of the change in band size and the apparent degradation of the truncated, nonfunctional protein. In contrast, both hearts ( Fig. 1D) and brains (not shown) from NCX1 SMϪ/Ϫ as well as NCX1 Fx/Ϫ mice express about half the normal (WT) level of NCX1, because both genotypes have one global, null-mutant NCX1 allele, but the SM-specific Cre recombinase is not activated in these tissues. In sum, these data demonstrate that the marked knockdown of NCX1 expression in NCX1 SMϪ/Ϫ mice is SM specific; moreover, homozygous global knockout is embryonic lethal (39) .
BP is Modestly Reduced in NCX1
SMϪ/Ϫ Mice NCX1 SMϪ/Ϫ mice appear normal and grow to adulthood, and there are no obvious behavioral or gross anatomical differences between these mice and either the WT or NCX1 Fx/Ϫ controls. Nevertheless, the fact that mice which overexpress NCX1 in SM have elevated BP (21) indicates that NCX1 plays a role in BP regulation and suggests that NXC1 SMϪ/Ϫ mice might also have a vascular phenotype. To test this, we compared BP in WT, NCX1
Fx/Ϫ , and NCX1 SMϪ/Ϫ mice with two invasive methods (Fig. 2) . First, the mean arterial BP (MBP) was measured with an intrafemoral catheter in mice under light isoflurane anesthesia. The results revealed that MBP in NCX1 Fx/Ϫ mice was comparable with WT controls and was significantly reduced in NCX1 SMϪ/Ϫ mice ( Fig. 2A) . Similar results were obtained with telemetric BP measurements on awake, free-moving mice: MBP was lower in NCX1 SMϪ/Ϫ mice than in NCX1 Fx/Ϫ or WT mice (Fig. 2B,a) . Interestingly, the heart rate was significantly slower in both NCX1
Fx/Ϫ and NCX1 SMϪ/Ϫ mice than in WT mice (Fig.  2B,b) . The similarity of the heart rate in NCX1
Fx/Ϫ and NCX1 SMϪ/Ϫ mice, despite the difference in BP, implies that the slow heart rate does not account for the low BP in the NCX1 SMϪ/Ϫ mice.
MT and Reactivity Are Attenuated by Reduced NCX1 Activity
To determine the contractile properties of the arteries from NCX1
Fx/Ϫ and NCX1 SMϪ/Ϫ mice, the diameter changes in isolated, pressurized mesenteric small arteries were measured. These arteries constrict spontaneously (ϭmyogenic reactivity) when intralumenal pressure is increased to more than 40 or 50 mmHg during superfusion with PSS at 35-37°C (48) . Arteries from NCX1 SMϪ/Ϫ mice exhibited significantly reduced myogenic reactivity (Fig. 3A) and MT (Fig. 3B) than did WT or NCX1 Fx/Ϫ arteries. Figure 3B illustrates the effects of the specific NCX inhibitor, SEA0400 (25) , on MT in these arteries. SEA0400 (1 M) reduced MT in WT mouse arteries to about the level of MT observed in NCX1 SMϪ/Ϫ arteries in the absence of SEA0400 but had no effect on MT in NCX1 SMϪ/Ϫ arteries. Thus the effect of SEA0400 on WT arteries is comparable with the effect of genetic NCX1 ablation. This lack of effect on arteries with markedly reduced NCX1 expression and the attenuated effect on MT in NCX1 Fx/Ϫ arteries (Fig. 3B) are evidence for the specificity of 1 M SEA0400.
Data on the mechanism by which SEA0400 reduces MT were obtained by simultaneous measurements of [Ca 2ϩ ] Cyt and diameter in WT arteries (Fig. 3C) . Previously, we demonstrated that the generation of MT is associated with a sustained rise in [Ca 2ϩ ] Cyt in myocytes within the walls of pressurized small arteries (48) . The confocal images of a fluo-4-loaded WT artery wall in Fig. 3C ,a show that [Ca 2ϩ ] Cyt (i.e., fluo-4 fluorescence) declines and the artery dilates when 1 M SEA0400 is applied (Fig. 3, C,a, i to ii, and C,b) . [Ca 2ϩ ] Cyt rises and the artery constricts when the SEA0400 is washed out (Fig. 3, C,a, ii to iii, and C,b) . The incomplete recovery of both fluo-4 fluorescence and MT were likely primarily due to the slow and incomplete washout of SEA0400, which is very hydrophobic. A modest bleaching of fluo-4, however, probably also contributed to the incomplete recovery of the initial fluorescent signal.
A supplemental video clip of the fluo-4 fluorescence data shown in Fig. 3C (1), the exposure of WT arteries to a sudden reduction in E Na induces an initial, transient vasodilation, followed by a sustained vasoconstriction (Fig. 4A) . A preincubation of WT arteries with 1 M SEA0400 for 10 min to block NCX reduces the dilation by about 50% and the constriction by about 90% (Fig. 4B) . Importantly, the magnitudes of both the transient vasodilation and the sustained vasoconstriction are similarly reduced in NCX1
Fx/Ϫ and NCX1 SMϪ/Ϫ arteries (Fig. 4 , A and C).
We have reported that nanomolar ouabain raises [Ca 2ϩ ] Cyt and augments MT in WT arteries; these effects are markedly inhibited by 1 M SEA0400, suggesting that they result from increased NCX-mediated Ca 2ϩ entry (21, 48) . To explore this role of NCX further, we compared the effects of ouabain on MT in arteries from WT, NCX1 Fx/Ϫ , and NCX1 SMϪ/Ϫ mice. As illustrated in Fig. 5, A and B, the ability of 100 nM ouabain to augment MT is significantly impaired in NCX1 Fx/Ϫ and, to a greater extent, in NCX1 SMϪ/Ϫ arteries. Fx/Ϫ arteries, ϳ60% of PD (which nearly obliterated the lumen), is similar to that in WT arteries (Fig. 6A,a) . In contrast, the 75 mM [K ϩ ] o -induced vasoconstriction is significantly reduced in NCX1 SMϪ/Ϫ arteries (Fig.  6A, a and b) . This may indicate that the maximal Ca 2ϩ entry through LVGCs is reduced in NCX1 SMϪ/Ϫ arteries because the 75 mM [K ϩ ] o -evoked vasoconstriction is abolished by the LVGC blocker, nifedipine (47) .
Agonist-Induced Vasoconstriction Is Impaired in NCX1
The maximal constriction to high-dose (3-100 M) PE also is significantly smaller in NCX1 SMϪ/Ϫ than in WT arteries; the constriction to 100 M PE is slightly, but not significantly, reduced in NCX1 Fx/Ϫ arteries (Fig. 6B, a and b) . Furthermore, both the high [K ϩ ] o (Fig. 6A,b) and PE (Fig. 6B,b) doseresponse curves are significantly depressed in NCX1 SMϪ/Ϫ compared with in NCX1
Fx/Ϫ arteries. Thus, for example, the , and 23 NCX1 SMϪ/Ϫ mice. *P Ͻ 0.05; **P Ͻ 0.01. B: MBP (a) and heart rate (HR; b), measured by telemetry during the light-on (low activity) 12 h on the indicated days over a 16-day period. bpm, Beats/min. Two-way ANOVA for the indicated pairs: *P Ͻ 0.05; ***P Ͻ 0.001; n ϭ 11 WT, 5 NCX1 Fx/Ϫ , and 7 NCX1 SMϪ/Ϫ mice.
PE constriction is reduced at all PE concentrations, but the concentration required for half-maximal constriction, ϳ0.35 M, is not significantly different in the NCX1 SMϪ/Ϫ and WT mouse arteries (Fig. 6B,b) 
LVGC Current Is Reduced in NCX1 SMϪ/Ϫ Myocytes
The aforementioned studies on high [K ϩ ] o -induced vasoconstriction raise the possibility that LVGC activity might be reduced in NCX1 SMϪ/Ϫ myocytes. Therefore, LVGC currents were measured in isolated mesenteric artery myocytes, using Ba 2ϩ as the current carrier (47) . Indeed, the data reveal that LVGC currents in NCX1 SMϪ/Ϫ mouse myocytes are smaller than the currents in myocytes from WT and NCX1 Fx/Ϫ mice (Fig. 7A, a-c) . This was confirmed by measuring both the current-voltage and G-V curves in myocytes from WT, NCX1 Fx/Ϫ , and NCX1 SMϪ/Ϫ mice. The amplitude of the LVGC, ϪI tail , was used as a measure of the conductance activated during the preceding depolarizing pulse (Fig. 7A,d) . Both the LVGC current and conductance are significantly smaller in NCX1 SMϪ/Ϫ myocytes compared with WT myocytes (Fig. 7B, a and b) . LVGC currents and conductances are, however, nearly identical in WT and NCX1 Fx/Ϫ myocytes (Fig. 7B, a and b) .
Block of NCX1 with SEA0400 Does Not Affect LVGC Current
Because the LVGC current is reduced in NCX1 SMϪ/Ϫ mice, we examined the effect of acute block of NCX1 with SEA0400 on LVGC current in dialyzed, patch-clamped WT myocytes. In the experiment illustrated in Fig. 7C , I Ba at ϩ10 mV is plotted as a function of time to control for the rundown of the current. The addition of 0.01% DMSO or 1 M SEA0400 in 0.01% DMSO had no detectable effect on I Ba . In another type of control experiment performed in a similar manner, ϳ85-90% of I Ba was blocked by 10 M nifedipine within 30 s (data not shown) (47) . These experiments demonstrate that an acute block of NCX1 by SEA0400 in WT myocytes does not reduce the nifedipine-sensitive LVGC current.
Voltage-Dependent Inactivation of LVGC Channels Is Unchanged in NCX1 SMϪ/Ϫ Myocytes
In cardiac-specific NCX1 knockout mice, too, LVGC current is decreased. In those myocytes, the current declines as a result of an increase in the rate of Ca 2ϩ -induced inactivation and increased Ca 2ϩ -dependent tonic inactivation of LVGCs, presumably because of the elevation of subsarcolemmal [Ca 2ϩ ] (32). Such a mechanism cannot explain our results because Ba 2ϩ was used as the current carrier in the arterial myocytes and because Ba 2ϩ does not support Ca 2ϩ -dependent inactivation (15) . Because LVGCs also exhibit voltage-dependent inactivation, however, we tested whether a shift in voltage dependence or an increase in inactivation could explain the reduction of LVGC current in NCX1 SMϪ/Ϫ mice. The results reveal that voltage-dependent inactivation is nearly identical in WT, NCX1
Fx/Ϫ , and NCX1 SMϪ/Ϫ myocytes (Fig. 8A) . Thus a change in inactivation cannot explain the reduction of LVGC current in NCX1 SMϪ/Ϫ myocytes.
Bay K 8644 Eliminates the Difference in LVGC Current Between Control and NCX1 SMϪ/Ϫ Myocytes
Another possible explanation for the reduced LVGC current in NCX1 SMϪ/Ϫ myocytes is that the expression of the channels is reduced. To get an indication of LVGC expression, we applied Bay K 8644, a potent activator of LVGCs (19) . In both WT and NCX1 SMϪ/Ϫ myocytes, 1 M Bay K 8644 increased LVGC current and maximum conductance and shifted the G-V curve to more negative potentials (Fig. 8B) . Interestingly, the current and conductance increases were greater in NCX1 SMϪ/Ϫ myocytes than in WT myocytes. In fact, Bay K 8644 eliminated the difference between the current, as well as the conductance, in WT and NCX1 SMϪ/Ϫ myocytes (Fig. 8B ). This implies that LVGC channel expression is comparable in WT and NCX1 SMϪ/Ϫ myocytes. transport does not significantly alter the amplitude or spatial spread of quantal Ca 2ϩ sparklets. Despite these similarities in the quantal events, Ca 2ϩ sparklet density (in sites/mm 2 ) and the overall level of sparklet activity (in nP s , where n is the number of quantal levels and P s is the probability that a sparklet site is active) (29) are significantly reduced in NCX1 SMϪ/Ϫ myocytes compared with NXC1 Fx/Ϫ myocytes (Fig. 9, A and B) . Bay K 8644 (500 nM), however, abolishes this difference (Fig. 9, B and C) . These Fx/Ϫ (n ϭ 9), and NCX1 SMϪ/Ϫ (n ϭ 16) arteries and WT arteries treated with 1 M SEA0400 (n ϭ 4). *P Ͻ 0.05; ***P Ͻ 0.001 vs. WT. results are consistent with the effect of Bay K 8644 on LVGC currents in NCX1 SMϪ/Ϫ and control (WT) myocytes (Fig. 8B) .
Bay K 8644 Eliminates the Difference in
Bay K 8644 Does Not Eliminate the Difference in Myogenic Reactivity Between WT and NCX1 SMϪ/Ϫ Arteries
Because LVGCs play a major role in myogenic constriction (8, 20) , one possibility is that the reduced myogenic reactivity observed in NCX1 SMϪ/Ϫ arteries (Fig. 3A) might be the result of the reduced LVGC activity in these arteries. Bay K 8644 normalizes LVGC current (Fig. 8) and Ca 2ϩ sparklet activity (Fig. 9 ) in NCX1 SMϪ/Ϫ arteries. Therefore, we reexamined the myogenic reactivity curves in WT and NCX1 SMϪ/Ϫ arteries in the presence of 1 M Bay K 8644. Figure 10 shows that Bay K 8644 constricts WT and NCX1 SMϪ/Ϫ arteries at 20 mmHg. The WT arteries then exhibit slight additional constriction when the intralumenal pressure is increased to 40 mmHg or more. In contrast, raising intralumenal pressure from 20 to 40 mmHg dilates the Bay K 8644-treated NCX1 SMϪ/Ϫ arteries, albeit, not as much as in the absence of Bay K 8644, increasing intralumental pressure further, and then causes only slight constriction. Importantly, Bay K 8644 did not affect the PD in either WT or NCX1 SMϪ/Ϫ arteries (not shown). Clearly, the NCX1 SMϪ/Ϫ arteries exhibit significantly less myogenic constriction than WT arteries at intralumenal pressures of 40 -120 mmHg, even in the presence of Bay K 8644. This difference apparently cannot be attributed to the reduced LVGC activity in NCX1 SMϪ/Ϫ arterial myocytes.
DISCUSSION
This study on the functional consequences of SM-specific knockout of NCX1 complements our earlier report that SMspecific overexpression of NCX1 elevates BP in mice (21) . The results we describe here strengthen the view that NCX1 plays an important role in vascular function.
NCX1 Fx/Ϫ Mice vs. WT Mice
A complication encountered in this study was the discovery that the Cre recombinase gene, under the control of the SM-MHC promoter, is activated during gametogenesis. Thus both the Cre SMϩ and Cre Ϫ mice used in this study all carried one floxed NCX1 allele and one null-mutant allele, in which NCX1 exon 11 was permanently deleted in all cells (METHODS). In other words, both Cre Ϫ and Cre SMϩ mice are, effectively, NCX1 heterozygotes; then, upon activation of the Cre gene in the SM cells of Cre SMϩ mice, exon 11 in the remaining floxed NCX1 allele is excised in these cells. Therefore, in many experiments, we employed two controls for the NCX1 SMϪ/Ϫ mice: WT mice and NCX1
Fx/Ϫ mice. It is noteworthy that the homozygous global null mutation of NCX1 is embryonic lethal (39) .
Relative to WT controls, the NCX1 Fx/Ϫ mice have a reduced expression of full-length NCX1 in all tissues tested (see Fig.  1D ). As a result, the NCX1 Fx/Ϫ arteries exhibit a reduced vasodilator response to SEA0400 (Fig. 3B) , a reduced low [Na ϩ ] o -induced vasodilation and vasoconstriction (Fig. 4B) , and a reduced vasoconstrictor response to low-dose ouabain (Fig. 5) 
Similarity of Effects of Genetic and Pharmacological Knockout of NCX1 on Arterial Function
In contrast to the situation in NCX1
Fx/Ϫ mice, vascular function is substantially impaired in NCX1 SMϪ/Ϫ mice. This is exemplified by the reduced myogenic reactivity and MT (Fig.  3) , attenuated vasoconstrictor responses to PE and high [K ϩ ] o (Fig. 6) , and reduced LVGC activity (Fig. 7) . Moreover, SM-specific knockout of NCX1 and an acute SEA0400 application to WT mouse arteries, i.e., a genetic and pharmacological reduction of NCX activity, respectively, have comparable effects on MT (Fig. 3) and on the responses to low [Na ϩ ] o (Fig.  4) and low-dose ouabain (Fig. 5 and Ref. 48 ). In rat small arteries, too, pharmacological blockade or antisense oligonucleotide knockdown of NCX1 reduces myogenic reactivity and tone (36) . As expected for a NCX-specific blocker [albeit somewhat controversial (38) ], SEA0400 has no effect on MT in NCX1 SMϪ/Ϫ mouse arteries (Fig. 3 ) or on LVGC current in WT artery myocytes (Fig. 7C) . These findings emphasize the importance of NCX1-mediated Ca 2ϩ entry in arterial function. Clearly, this mode of NCX operation is a normal mode and, perhaps, the dominant mode in ASMCs in arteries with tone.
The NCX1-mediated, low [Na ϩ ] o -induced initial vasodilation and, later, sustained vasoconstriction (Fig. 4A ) raise the SMϪ/Ϫ myocytes in the absence (Ctrl) and presence of 500 nM Bay K 8644; *P Ͻ 0.05. C: the sparklet activity (nPs; n ϭ number of quantal levels; Ps ϭ probability that a sparklet site is active) is plotted for 8 NXC1
Fx/Ϫ and 7 NCX1 SMϪ/Ϫ myocytes in the absence (Ctrl) and presence of 500 nM Bay K 8644; *P Ͻ 0.05. Note that Bay K 8644 abolished the differences between NXC1 Fx/Ϫ and NCX1 SMϪ/Ϫ myocytes in B and C.
interesting question of mechanism(s). The vasoconstriction appears to be explicable by the decline in the inwardly directed E Na ; this is expected to promote net Ca 2ϩ gain via NCX1 (Introduction) and direct activation of myosin light chain kinase and, therefore, ASMC contraction. The explanation for the early vasodilation is less clear. About half of the dilation is blocked by bath-applied SEA0400 or by SM-specific NCX1 knockout and therefore appears to be attributable to SM NCX1 (Fig. 4C) . Two possible mechanisms that could also be triggered by NCX-mediated Ca 2ϩ entry and a rise in [Ca 2ϩ ] Cyt are 1) the rapid activation of large-conductance Ca 2ϩ -activated K ϩ channels in ASMCs (7) and 2) the Ca 2ϩ -induced activation of nitric oxide synthase in endothelial cells (43 To distinguish between the second and third possibilities, we employed sparklet analysis. The evidence that the magnitude and spatial spread of individual sparklets do not differ in NCX1 SMϪ/Ϫ and NCX1 Fx/Ϫ myocytes indicates that the individual quanta are similar; this also implies that the singlechannel conductance of the LVGCs is not altered. Thus the reduced LVGC current must be due to a decreased openchannel probability. This fits with the observed reduction in sparklet activity (number of active sites and probability of activation) in NCX1 SMϪ/Ϫ myocytes (Fig. 9) . LVGC activity plays a critical role in the maintenance of MT (8, 20, 47) , and the reduced LVGC activity might be the cause of the reduced MT and low BP in NCX1 SMϪ/Ϫ mice. Figure 10 shows, however, that myogenic constriction is reduced in NCX1 SMϪ/Ϫ arteries, compared with WT arteries, even in the presence of 1 M Bay K 8644, which abolishes the difference between LVGC activity in these arteries (Fig. 8) . Furthermore, evidence presented in the accompanying article (37) implies that the depressed LVGC activity is a consequence of the low [Ca 2ϩ ] Cyt and reduced Ca 2ϩ -dependent protein kinase C activity that likely results from a marked knockdown of NCX1 expression. Indeed, an acute inhibition of NCX by SEA0400, which does not block LVGCs (Fig. 7C) , lowers [Ca 2ϩ ] Cyt and reduces MT in WT arteries (Fig. 3, B and C) . The fact that NCX1 SMϪ/Ϫ mouse arteries have significantly reduced MT therefore implies that [Ca 2ϩ ] Cyt may also be low in these ASMCs. Thus the attenuation of MT (Fig. 3A) , LVGC activity (Fig. 7) , and high [K ϩ ] o -induced vasoconstriction (Fig. 6A) SMϪ/Ϫ mice because high PE-induced vasoconstriction in Ca 2ϩ -free media is not attenuated (data not shown). A likely possibility is that receptoroperated channels (ROCs), which are an important source of Ca 2ϩ during receptor activation (44) , especially at high catecholamine concentrations (30) , may be downregulated in NCX1 SMϪ/Ϫ arteries. In primary cultured arterial myocytes, a knockout of NCX1 markedly decreases the expression of transient receptor potential canonical 6 channel protein (a component of ROCs) and reduces ROC activity (33) .
Correlation Between BP and In Vitro MT
Davis and Hill (8) observed that the level of tone in isolated arteries "is often comparable to that observed in the same vessels in vivo." This implies that MT in isolated arteries predicts not only in vivo vascular tone but BP as well, as exemplified by the increased MT and elevated BP in ␣ 2 Na ϩ -pump heterozygous null mutant mice (48) . The present report extends this concept by showing that, at the other end of the spectrum, SM-specific knockout of NCX1 not only reduces MT but lowers BP as well. Conversely, SM-specific overexpression of NCX1 is associated with elevated BP (21) ; an increase in MT is anticipated, but this has not yet been tested in arteries from these mice.
Most important, the present report adds to the growing body of evidence that ␣ 2 Na ϩ pumps and adjacent NCX1 are critical mechanisms that link Na ϩ metabolism to BP regulation (6) . Recently, Wirth and colleagues (45) suggested that salt-dependent hypertension is specifically mediated by a G 12 -G 13 protein-coupled receptor-mediated pathway, but our findings do not support their conclusion. On the contrary, our results suggest that the modulation of NCX1 activity directly affects Ca 2ϩ metabolism and the level of [Ca 2ϩ ] Cyt and thus likely acts via myosin light chain kinase to modulate vasoconstriction. In conjunction with earlier reports (12, 13, 21, 48) , the present study is consistent with the view that retained salt can act via the endogenous ouabain-␣ 2 Na ϩ pump-NCX1 pathway to elevate BP without directly involving G protein-coupled receptor pathways (6) . Of course, the downstream effects are likely to be modulated by the G protein-coupled receptor pathways that regulate the Ca 2ϩ sensitivity of the contractile apparatus (24) .
We conclude that the arterial SM NCX1 is needed to maintain the normal [Ca 2ϩ ] Cyt , MT, and BP. This direct link to NaCl metabolism is often overlooked in studies of the mechanisms that influence the BP in salt-dependent hypertension.
